ClinicalTrials.Veeva

Menu

Korean Red Ginseng Rg3 Extract on Arterial Stiffness and Blood Pressure (KRAB)

U

Unity Health Toronto

Status and phase

Completed
Phase 1

Conditions

Arterial Stiffness, Blood Pressure

Treatments

Dietary Supplement: Ginseng
Dietary Supplement: Wheat Bran

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the study is to evaluate the acute effect of a standardized extract of KRG (Rg3-KRG) consisting of 30% total ginsenosides, including 10% Rg3 ginsenoside on arterial stiffness and blood pressure, as measured by the following parameters: aortic augmentation index, peripheral blood pressure, central blood pressure

Enrollment

24 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Healthy
  • Age 18-70 years
  • BMI < 30 kg/m2
  • Brachial systolic blood pressure < 140 mmHg
  • Brachial diastolic blood pressure < 90 mmHg

Main Exclusion Criteria:

  • BMI >30kg/m2
  • Hypertensive (brachial systolic BP ≥140mmHg and/or diastolic BP ≥90mmHg)
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

24 participants in 2 patient groups, including a placebo group

Ginseng
Experimental group
Description:
Encapsulated 400mg Rg3-KRG extract
Treatment:
Dietary Supplement: Ginseng
Wheat Bran
Placebo Comparator group
Description:
400mg Wheat Bran capsule
Treatment:
Dietary Supplement: Wheat Bran

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems